| Dr Andrew V Chuma, MD | |
|
460 Creamery Way, Suite 103, Exton, PA 19341-2533 | |
| (610) 384-8300 | |
| (610) 384-8885 |
| Full Name | Dr Andrew V Chuma |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 31 Years |
| Location | 460 Creamery Way, Exton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255301339 | NPI | - | NPPES |
| 0001697042003 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD064172L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chester County Hospital | West chester, PA | Hospital |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Ent Alliance Llc | 7416963988 | 39 |
News Archive
EQ Labs, Inc., a manufacturer and distributor of the EQ Smart Energy Drink® effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
› Verified 6 days ago
| Entity Name | Pinnacle Ent Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538230313 PECOS PAC ID: 7416963988 Enrollment ID: O20060222000064 |
News Archive
EQ Labs, Inc., a manufacturer and distributor of the EQ Smart Energy Drink® effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew V Chuma, MD 460 Creamery Way, Suite 103, Exton, PA 19341-2533 Ph: (610) 384-8300 | Dr Andrew V Chuma, MD 460 Creamery Way, Suite 103, Exton, PA 19341-2533 Ph: (610) 384-8300 |
News Archive
EQ Labs, Inc., a manufacturer and distributor of the EQ Smart Energy Drink® effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day.
With CAR T cell therapy, a patient's own immune cells are genetically modified and inserted back into the body to find and kill cancer. This form of immunotherapy has already revolutionized some cancer treatments, but once the CAR T cells are inside a patient, where do they go? How do doctors know that they have successfully reached their target and that they are continuing to fight disease weeks, months, or even years later?
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression.
DRG International, a leading international medical diagnostic company, will showcase the NEW DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.
› Verified 6 days ago
Dr. Joseph L Smith Ii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532 Fax: 610-363-0210 | |
Dr. Adam J Mariotti, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532 Fax: 610-363-0210 | |
Jillian Mattioni, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 Creamery Way Ste 103, Exton, PA 19341 Phone: 610-384-8300 Fax: 610-384-8885 | |
Dr. Michael A. Picariello, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532 Fax: 610-363-0210 | |
Dr. Alexander C. Keszeli, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Arrandale Blvd, Exton, PA 19341 Phone: 610-363-2532 Fax: 610-363-0210 | |
Dr. Michael A. Hoffmann, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 Creamery Way, Exton, PA 19341 Phone: 610-384-8300 |